Celularity

-$0.26 (-3.31%) Today
$0.00 (0.00%) As of 8:50 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celularity and other ETFs, options, and stocks.

About CELU

Celularity, Inc. a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other.

CEO
Robert Joseph Hariri Gordon
Employees
225
Headquarters
Florham Park, New Jersey
Founded
2016

CELU Key Statistics

Market cap
1.05B
Price-Earnings ratio
6.22
Dividend yield
—
Average volume
632.53K
High today
$8.39
Low today
$7.59
Open price
$7.71
Volume
274.22K
52 Week high
$13.40
52 Week low
$3.63

CELU Earnings

-$0.48
-$0.19
$0.11
$0.40
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.48 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure